Condition
Idiopathic Pulmonary Fibrosis(IPF) clinical trials and research
Research outlook What's coming for Idiopathic pulmonary fibrosis: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Idiopathic Pulmonary Fibrosis(IPF) clinical trials that are recruiting, in China. By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
SV001 for safety, tolerability, and immune response in people with idiopathic pulmonary fibrosis
This trial will test whether SV001 is safe, well tolerated, and how it behaves in the body in people with idiopathic pulmonary fibrosis.
-
Jin-shui Huan-xian formula to slow IPF-related lung decline
A 52-week, randomized, double-blind, placebo-controlled trial tests whether Jin-shui Huan-xian Formula slows the loss of lung function in adults with idiopathic pulmonary fibrosis.
Quick answers
How many Idiopathic Pulmonary Fibrosis(IPF) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.